Welcome Login

We’re proud to be supporting Dyslexia Awareness Day!

Dyslexia is a neurological difference and can have a significant impact during education, in the workplace and in everyday life. People with dyslexia have difficulty manipulating the sounds and letters of language, but as each person is unique, so is everyone’s experience of dyslexia. It can range from mild to severe, and it can co-occur with other learning differences. It usually runs in families and is a life-long condition.

Approximately 15 per cent of people have dyslexia, which equates to about 6 million in the United Kingdom.

It is important to remember that there are positives to thinking differently. Dyslexics show strengths in areas such as reasoning, problem-solving and in visual and creative fields. Many people with dyslexia become successful engineers due to their creative vision and strong ability to solve problems.

If you look around, there are many famous dyslexics that have helped change the world. Thomas Edison, inventor of the light bulb had dyslexia, as did inventor of the telephone, Alexander Bell. Space Scientist, Mechanical Engineer and Science Communicator, Maggie Aderi-Pocock and Professor Elizabeth Blackburn who discovered the molecular nature of telomeres also had dyslexia, along with Creator of Ford Motor Company, Henry Ford and CEO and inventor of Apple Inc, Steve Jobs.

Here at the IET, we’re dedicated to our continued commitment to equality, diversity and inclusion, and as one of the largest PEIs in the world, we have a duty to promote engineering to everybody and encourage organisations to do more around promoting the importance of embracing Equality, Diversity and Inclusion.

We’re proud to support Dyslexia Awareness Day and recognise that dyslexia is a positive difference that has the potential to change the world.

COVID-19 (Coronavirus)

We are monitoring the rapidly changing situation, to view our latest updates please read this more detailed statement or read about how you can help support efforts to tackle COVID-19.